Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIOUS (JCOG1310): Perioperative vs postoperative mFOLFOX6 in lower rectal cancer with suspected lateral pelvic node metastasis
jRCTs031180230Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin + fluorouracil + leucovorin in rectal cancer, rectal adenocarcinoma and Rectal adenosquamous carcinoma (RASC) (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
oxaliplatin + fluorouracil + leucovorin
03
Conditions
rectal cancerrectal adenocarcinomaRectal adenosquamous carcinoma (RASC)
Beyond the preview
Go deeper on jRCTs031180230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180230.